Government secures deal for 60m doses of potential coronavirus vaccine : International de Inglaterra
The UK Government has secured a deal for 60 million doses of a potential vaccine against Covid-19.
Officials have been able to sign off on an agreement with pharmaceutical companies GlaxoSmithKline and Snaofi Pastuer for the potential vaccines, reports the Daily Star.
Medical experts across the country are in the process of conducting trials as they continue their battle to find a cure against the virus.
If the trials turn out to be a success then Scots could be among those to be vaccinated at the beginning of 2021.
Clinical trials for the potential cure are being carried out in specialist centres across Scotland at the moment.
The government has already secured four different types of immunisation and 250 million doses.
Any vaccine is considered key in bringing the country entirely out of lockdown and back to a more normal way of living.
Business Secretary, Alok Sharma, said: “Our scientists and researchers are racing to find a safe and effective vaccine at a speed and scale never seen before.
“While this progress is truly remarkable, the fact remains that there are no guarantees.
“In the meantime, it is important that we secure early access to a diverse range of promising vaccine candidates, like GSK and Sanofi, to increase our chances of finding one that works so we can protect the public and save lives.”
It is not clear how much it has cost to secure access to the potential vaccine.
Kate Bingham, chair of the government’s vaccines taskforce, said: “Through this agreement with GSK and Sanofi, we can add another type of vaccine to the three different types of vaccine we have already secured.
“This diversity of vaccine types is important because we do not yet know which, if any, of the different types of vaccine will prove to generate a safe and protective response to Covid-19.
“Whilst this agreement is very good news, we mustn’t be complacent or over optimistic.
“The fact remains we may never get a vaccine and if we do get one, we have to be prepared that it may not be a vaccine which prevents getting the virus, but rather one that reduces symptoms.”